Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors: which perspectives? We asked Igor Puzanov (Senior Vice President, Clinical Investigations Director, Center of Early Phase Clinical Trials Chief, Melanoma Section Buffalo, New York ) during the IMMUNOTHERAPY & MELANOMA BRIDGE Congress.